RUcore: Rutgers University Community Repository
Dibenzoylmethane induced cell cycle arrest in human colon cancer cells and its pharmacokinetic disposition in the rats
Descriptive
TitleInfo
Title
Dibenzoylmethane induced cell cycle arrest in human colon cancer cells and its pharmacokinetic disposition in the rats
Name
(type = personal)
NamePart
(type = family)
Hong
NamePart
(type = given)
Jin-Liern
DisplayForm
Jin-Liern Hong
Role
RoleTerm
(authority = RUETD)
author
Name
(type = personal)
NamePart
(type = family)
Kong
NamePart
(type = given)
Ah-Ng
Affiliation
Advisory Committee
DisplayForm
Ah-Ng Kong
Role
RoleTerm
(authority = RUETD)
thesis committee chair
Name
(type = personal)
NamePart
(type = family)
Reddy
NamePart
(type = given)
Bandaru
Affiliation
Advisory Committee
DisplayForm
Bandaru S. Reddy
Role
RoleTerm
(authority = RUETD)
dissertation committee member
Name
(type = personal)
NamePart
(type = family)
Huang
NamePart
(type = given)
Mou-Tuan
Affiliation
Advisory Committee
DisplayForm
Mou-Tuan Huang
Role
RoleTerm
(authority = RUETD)
outside dissertation committee member
Name
(type = corporate)
NamePart
Rutgers University
Role
RoleTerm
(authority = RULIB)
degree grantor
Name
(type = corporate)
NamePart
Graduate School-New Brunswick
Role
RoleTerm
(authority = RULIB)
school
TypeOfResource
Text
Genre
(authority = marcgt)
theses
OriginInfo
DateCreated
(qualifier = exact)
2007
DateOther
(qualifier = exact);
(type = degree)
2007
Language
LanguageTerm
(authority = ISO 639-3:2007);
(type = text)
English
PhysicalDescription
Form
(authority = marcform)
electronic
InternetMediaType
application/pdf
InternetMediaType
text/xml
Extent
xi, 72 pages
Abstract
(type = abstract)
The phytochemical dibenzoylmethane (DBM) is a minor constituent of licorice and has been shown to inhibit the growth of various types of cancer cells in vitro and prevent the carcinogenesis in various animal models. In previous studies in our laboratory it was found that DBM effectively inhibited colorectal carcinogenesis in APC(Min/+) mice. However, little is known regarding the cellular and molecular mechanisms underlying this inhibition, and the pharmacokinetic disposition of DBM still remains unclear. In the first part of this thesis, the anti-proliferative activity of DBM in human colon carcinoma HT-29 cells and the possible molecular mechanisms were investigated. We found that DBM inhibited HT-29 cell proliferation and that this inhibition is associated with cell cycle arrest at G1 phase without inducing apoptosis. DBM-treatment dose-dependently down-regulated various cell cycle regulatory proteins including Cyclin D1, c-Myc and the phosphorylation of retinoblastoma protein. It appears that decreased mRNA transcription and proteasome-mediated protein degradation were involved in the DBM-induced down-regulation of those proteins. At the same time, p21CIP1, a negative cell cycle regulatory protein, was up-regulated by DBM at both protein and mRNA levels. Taken together, our results from this cell culture studies suggest that DBM inhibited HT-29 cell growth by modulating cell cycle regulatory proteins leading to the induction of cell cycle arrest. In the second part of my thesis, I developed and validated a rapid and sensitive high-performance liquid chromatography (HPLC) assay to determine the concentrations of DBM in the rat plasma, then followed by examining the in vivo pharmacokinetics of DBM in the rats by using this HPLC assay with UV detector. The data indicate that DBM followed a linear pharmacokinetics within the dose ranges tested. The volume of distribution at steady state was about 7.1 L with a systemic clearance of 0.72 L/Kg and t1/2 of 13.23 hr. The oral bioavailability of DBM was approximately 11%. In summary, this thesis investigated the in vitro molecular mechanism of DBM-induced cell cycle arrest in HT-29 cells as well as the in vivo pharmacokinetic disposition of DBM in the rats.
Note
(type = degree)
M.S.
Note
(type = bibliography)
Includes bibliographical references (p. 69-71).
Subject
(authority = RUETD)
Topic
Pharmaceutical Science
Subject
(authority = ETD-LCSH)
Topic
Pharmacokinetics
Subject
(authority = ETD-LCSH)
Topic
Chemical kinetics
Subject
(authority = ETD-LCSH)
Topic
Pharmacology
Subject
(authority = ETD-LCSH)
Topic
Dibenzoylmethane
RelatedItem
(type = host)
TitleInfo
Title
Graduate School - New Brunswick Electronic Theses and Dissertations
Identifier
(type = local)
rucore19991600001
Identifier
(type = hdl)
http://hdl.rutgers.edu/1782.2/rucore10001600001.ETD.13473
Identifier
(type = FEDORA_PID)
rutgers-lib:21310
Identifier
ETD_191
Identifier
(type = doi)
doi:10.7282/T3NZ883B
Location
PhysicalLocation
(authority = marcorg);
(displayLabel = Rutgers, The State University of New Jersey)
NjNbRU
Genre
(authority = ExL-Esploro)
ETD graduate
Back to the top
Rights
RightsDeclaration
(AUTHORITY = GS);
(ID = rulibRdec0006)
The author owns the copyright to this work.
Copyright
Status
Copyright protected
Availability
Status
Open
AssociatedEntity
(AUTHORITY = rulib);
(ID = 1)
Name
JIN-LIERN HONG
Role
Copyright holder
Affiliation
Rutgers University. Graduate School-New Brunswick
RightsEvent
(AUTHORITY = rulib);
(ID = 1)
Type
Permission or license
Detail
Non-exclusive ETD license
AssociatedObject
(AUTHORITY = rulib);
(ID = 1)
Type
License
Name
Author Agreement License
Detail
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.
Back to the top
Technical
Format
(TYPE = mime);
(VERSION = )
application/x-tar
FileSize
(UNIT = bytes)
1758208
Checksum
(METHOD = SHA1)
81b457229c662df2f185a722e4e44dd736793a1d
ContentModel
ETD
CompressionScheme
other
OperatingSystem
(VERSION = 5.1)
windows xp
Format
(TYPE = mime);
(VERSION = NULL)
application/x-tar
Back to the top
Statistical Profile